POINT Biopharma Global Inc. (PNT)

NASDAQ: PNT · Real-Time Price · USD

12.50

0.02 (0.16%)

At close: Dec 26, 2023, 9:00 PM

POINT Biopharma Global Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	98.29M	-45.9M	-13.37M	-36.9K
Depreciation & Amortization	1.4M	11.84K	n/a	n/a
Stock-Based Compensation	3.55M	2.3M	1.76M	n/a
Other Working Capital	76.03M	846.16K	-292.65K	n/a
Other Non-Cash Items	-1.95M	n/a	5.35K	36.9K
Deferred Income Tax	1.39M	65.59K	n/a	n/a
Change in Working Capital	80.85M	-1.18M	3.3M	n/a
Operating Cash Flow	183.52M	-44.7M	-8.3M	n/a
Capital Expenditures	-12.77M	-8.8M	-9.8M	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	-253.5M	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a
Investing Cash Flow	-266.26M	-8.8M	-9.8M	n/a
Debt Repayment	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	130.36M	281.77M	28.65M	n/a
Financial Cash Flow	130.36M	281.77M	28.65M	n/a
Net Cash Flow	47.61M	228.27M	10.55M	n/a
Free Cash Flow	170.75M	-53.5M	-18.1M	n/a